STAT+: Pharmalittle: We’re reading about CAR-T drugs for myeloma, CVS rebate credits, and more
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
Category: Pharmalot
STAT+: Pharmalittle: We’re reading about a liver-drug approval, pharma’s positive outlook, and more
And so, another working week will soon come to a close. Not a moment too…
STAT+: Pharmalittle: We’re reading about BIO cutting ties with WuXi, EU pharma rules, and more
Rise and shine, everyone, another busy day is on the way. We can tell because…
.jpg)
STAT+: Pharma loses a key battle over a state law concerning 340B pharmacies
In a setback to the pharmaceutical industry, a U.S. appeals court has upheld an Arkansas…
STAT+: Pharmalittle: We’re reading about Amazon delivering Zepbound, hemophilia treatments, and more
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
STAT+: Pharmalittle: We’re reading about a failed schizophrenia drug trial, a Pfizer cancer drug, and more
Top of the morning to you, and a fine one it is. Sunny skies and…
STAT+: Pharmalittle: We’re reading about Wegovy approved for heart risks, an ALS drug puzzle, and more
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: We’re reading about Lilly Alzheimer’s drug adcomm, Amylyx ALS drug flop, and more
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Pharmalittle: We’re reading about a Lilly obesity-drug ad, a $35 cap on inhalers, and more
Rise and shine, everyone, another busy day is on the way. Moreover, this is shaping…
STAT+: Boehringer Ingelheim to cap asthma inhaler out-of-pocket costs at $35
Facing criticism over its pricing, Boehringer Ingelheim plans to cap out-of-pocket costs at $35 a…
STAT+: Pharmalittle: We’re reading about HIV drug resistance, march-in rights, and more
Good morning, everyone, and how are you today? We are doing just fine, thank you….
STAT+: WTO proposal for Covid diagnostics and therapeutics waiver is abandoned
After 18 months of debate, the World Trade Organization failed to adopt a controversial proposal…
STAT+: Pharmalittle: We’re reading about Ozempic tackling kidney disease, OTC birth control, and more
Good morning, everyone, and how are you today? We are doing just fine, despite a…
STAT+: White House is told the big three PBMs are ‘everything wrong with this industry’
As part of its battle to blunt the growing cost of medicines, the White House…
STAT+: Pharmalittle: We’re reading about a nixed Medicare negotiation lawsuit, an Obamacare challenge, and more
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Many costly generic drugs are unavailable at Amazon, Cuban, and other alternative pharmacies
A growing number of alternative pharmacies — such as those run by Costco, Amazon, and…
STAT+: Pharmalittle: We’re reading about RSV vax link to GSB, a Pfizer donation, and more
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Pharmalittle: We’re reading about White House eyeing PBMs, Pfizer CEO’s frustrations, and more
Top of the morning to you, and a fine one it is. Cold winds and…
STAT+: White House to hold a listening session on reforming pharmacy benefit managers
In a bid to combat prescription drug costs, the White House will hold a listening…
STAT+: Pharmalittle: We’re reading about the FTC vs. PBMs, FDA adcomm voting and more
Hello, everyone, and how are you today? We are doing just fine, thank you, especially…
STAT+: FTC says pharmacy benefit managers are stonewalling requests for information
A much-anticipated inquiry by U.S. antitrust regulators into pharmaceutical industry middlemen has been stymied because…
STAT+: Pharmalittle: We’re reading about Congress punts PBM reform, another obesity drug and more
Rise and shine, everyone, another busy day is on the way. Sadly, gray skies are…
STAT+: Pharmalittle: We’re reading about state moves on drug pricing, an asthma med for kids and more
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Oregon suspends a portion of its drug transparency law found to be unconstitutional
In a victory for the pharmaceutical industry, Oregon officials have suspended a portion of a…
STAT+: Amgen’s rheumatoid arthritis drug Enbrel targeted for first-in-the-nation price limit in Colorado
WASHINGTON — Colorado is pioneering a new way for states to crack down on prescription…
STAT+: Pharmalittle: We’re reading about a pharma job slowdown, diet drugs boosting GDP, and more
And so, another working week will soon draw to a close. Not a moment too…
STAT+: FDA gives a mixed response to a petition seeking greater clinical trial transparency
The U.S. Food and Drug Administration told an advocacy group that it is not planning…
STAT+: Pharmalittle: We’re reading about India-made versions of Wegovy, an RSV vaccine scramble, and more
Top of the morning to you, and a fine one it is. Clear blue skies…
STAT+: Novavax and Gavi end a bitter dispute over Covid-19 vaccines with a refund up to $400 million
After a contentious dispute, Novavax has agreed to refund up to $400 million to the…
STAT+: Pharmalittle: We’re reading about a CEO change at AbbVie, a long-acting HIV drug, and more
Rise and shine, everyone. The middle of the week is upon us. Have heart, though….
STAT+: Pharmalittle: We’re reading about weight loss drugs, a cell therapy for melanoma, and more
Good morning, everyone, and welcome to another working week, which is getting off to a…
STAT+: A lawsuit over a controversial Sanofi drug shortage is unexpectedly revived
A U.S. appeals court revived a controversial lawsuit brought by nearly two dozen people who…
STAT+: Pharmalittle: We’re reading about kids taking Wegovy, telehealth for abortion pills, and more
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Hospital claims it was ‘drastically’ overcharged by pharma in a federal drug discount program
For several years, some of the world’s largest pharmaceutical companies that participate in a U.S….
STAT+: Pharmalittle: We’re reading about a FTC probe into GPOs, a frostbite drug, and more
Top of the morning to you, and a fine one it is. Clear blue skies…
STAT+: Leaked version of EFTA-India free trade deal sparks alarm over access to medicines
A leaked version of a proposed agreement between India and the European Free Trade Association…
STAT+: FTC to probe the role of middlemen in worsening drug shortage crisis
The Federal Trade Commission is launching a probe into the extent to which group purchasing…
STAT+: Pharmalittle: We’re reading about slow uptake of an Alzheimer’s drug, an opioid lawsuit, and more
Hello, everyone, and how are you today? We are doing just fine, thank you, especially…
STAT+: Pharmalittle: We’re reading about a tossed PhRMA lawsuit, secrecy clauses, and more
Rise and shine, everyone, another busy day is on the way. However, the pace this…
STAT+: Pharmalittle: We’re reading about Moderna’s RSV vaccine, Aurobindo problems, and more
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Major generic maker Aurobindo cuts production at a key plant amid concerns over shortages
Aurobindo, which is one of the largest generic drug makers, has halted some production at…
STAT+: Pharmalittle: We’re reading about a U.S. vaccine panel, an abortion pill, and much more
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Pharmalittle: We are reading about Catalent concerns, a congressional hearing, and more
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT+: Years into an addiction crisis, a med school lecture still minimized opioid risks
Amid ongoing concern over opioid addiction, a university in Florida has been criticized for allowing…
.jpg)
STAT+: Pharmalittle: We’re reading about worries over a Novo deal, a PBM bill, and more
Rise and shine, everyone. The middle of the week is upon us. Have heart, though….
STAT+: Colombia proceeds with plans to issue a compulsory license for an HIV medicine sold by GSK’s ViiV
The Colombian government has taken a significant step toward issuing a compulsory license for a…
STAT+: Pharmalittle: We’re reading about a lawsuit against J&J, Express Scripts dealings, and more
Top of the morning to you, and a fine one it is. Clear blue skies…
STAT+: Diabetes treatments have improperly listed patents that should be removed, analysis finds
More than half of the injector-pen patents for several widely used diabetes treatments — including…
STAT+: Pharmalittle: We’re reading about Novo buying Catalent, Amgen’s obesity drug, and more
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: We’re reading about opioid settlements, an OTC birth control pill, and more
And so, another working week will soon draw to a close. Not a moment too…